Tianxing Zhou

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Chemotherapy Reawakens Dormant Disseminated Pancreatic Cancer Cells in the Liver by Promoting Senescent Hepatocyte-Induced Neutrophil Extracellular Traps.

Chemotherapy Reawakens Dormant Disseminated Pancreatic Cancer Cells in the Liver by Promoting Senescent Hepatocyte-Induced Neutrophil Extracellular Traps.

Journal: Cancer research

Published: January 12, 2026

Senescence as the Next Frontier in Cancer Research: Navigating the Rising Tide of Geriatric Oncology.

Senescence as the Next Frontier in Cancer Research: Navigating the Rising Tide of Geriatric Oncology.

Journal: Cancer discovery

Published: November 24, 2025

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Journal: Cancer biology & medicine

Published: October 17, 2025

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

Journal: Cancer biology & medicine

Published: September 30, 2025

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Journal: Cancer discovery

Published: September 18, 2025

AI-Guided SERS Defines a Pan-Cancer Diagnostic Biomarker.

AI-Guided SERS Defines a Pan-Cancer Diagnostic Biomarker.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 23, 2025

Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy.

Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy.

Journal: Communications biology

Published: July 10, 2025

KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy.

KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy.

Journal: Gut

Published: June 30, 2025

Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.

Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 02, 2025

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

Journal: Nature communications

Published: May 29, 2025

HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma.

HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma.

Journal: Biological procedures online

Published: May 11, 2025

Reply.

Reply.

Journal: Gastroenterology

Published: May 09, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026